Meeder Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,960
| Closed | -$448K | – | 850 |
|
|
2025
Q1 | $448K | Buy |
+26,960
| New | +$448K | 0.03% | 184 |
|
|
2021
Q4 | – | Sell |
-24
| Closed | – | – | 1095 |
|
|
2021
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 2461 |
|
|
2021
Q2 | $1K | Hold |
24
| – | – | ﹤0.01% | 2295 |
|
|
2021
Q1 | $1K | Sell |
24
-43
| -64% | -$1.79K | ﹤0.01% | 2162 |
|
|
2020
Q4 | $4K | Sell |
67
-9
| -12% | -$537 | ﹤0.01% | 1252 |
|
|
2020
Q3 | $3K | Sell |
76
-36
| -32% | -$1.42K | ﹤0.01% | 1697 |
|
|
2020
Q2 | $5K | Sell |
112
-3,133
| -97% | -$140K | ﹤0.01% | 1500 |
|
|
2020
Q1 | $136K | Sell |
3,245
-3,066
| -49% | -$128K | 0.01% | 648 |
|
|
2019
Q4 | $271K | Buy |
6,311
+135
| +2% | +$5.8K | 0.02% | 520 |
|
|
2019
Q3 | $221K | Buy |
6,176
+5,889
| +2,052% | +$211K | 0.01% | 583 |
|
|
2019
Q2 | $8K | Sell |
287
-723
| -72% | -$20.2K | ﹤0.01% | 1510 |
|
|
2019
Q1 | $27K | Sell |
1,010
-2,599
| -72% | -$69.5K | ﹤0.01% | 998 |
|
|
2018
Q4 | $57K | Buy |
3,609
+3,336
| +1,222% | +$52.7K | 0.01% | 776 |
|
|
2018
Q3 | $6K | Buy |
+273
| New | +$6K | ﹤0.01% | 1278 |
|
|
2018
Q2 | – | Sell |
-124
| Closed | -$3K | – | 1544 |
|
|
2018
Q1 | $3K | Hold |
124
| – | – | ﹤0.01% | 1311 |
|
|
2017
Q4 | $4K | Buy |
+124
| New | +$4K | ﹤0.01% | 1347 |
|